RARE vs TASK
Ultragenyx (RARE) versus Taskus Inc (TASK) — a side-by-side from cached financials, not a winner call.
Ultragenyx (RARE) is a biotechnology company listed on US.
Taskus Inc (TASK) is a information technology services company listed on NASDAQ.
Latest reported RARE revenue for 2024-12-31 was $560.2M. Net income was -$569.2M. Revenue was up 29.0% from 2023-12-31 to 2024-12-31. RARE currently screens at market cap $2.79B.
Latest reported TASK revenue for 2024-12-31 was $995.0M. Net income was $45.9M. Revenue was up 7.6% from 2023-12-31 to 2024-12-31. TASK currently screens at market cap $492.7M and trailing P/E 4.8.
RARE currently screens at market cap $2.79B. TASK currently screens at market cap $492.7M and trailing P/E 4.8.
Not investment advice. Open the RARE and TASK stock pages for the full models.
Not investment advice.